Skip to main content
Terminated

Validation of the MiCK Assay

By April 24, 2017No Comments

Condition

Mesothelioma, Small Cell Lung Cancer, NSCLC

Estimated Enrollment: 21

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective

Study ID Numbers: MAYO1000

Study First Received: January 16, 2013

Last Updated: September 14, 2016

Estimated Primary Completion Date: January 2015

 

Primary Outcome Measures:

Complete response and survival

Sponsors and Collaborators:

DiaTech Oncology

Website Link: https://ClinicalTrials.gov/show/NCT01770665

Leave a Reply